Tanshinone IIA ameliorates seawater exposure-induced lung injury by inhibiting aquaporins (AQP) 1 and AQP5 expression in lung

Respiratory Physiology and Neurobiology

Volumn 176, Issue 1-2, 2011, Pages 39-49

  Li, Jiahuan ^a,c   Xu, Min ^b   Fan, Qixin ^a   Xie, Xiaoyan ^a   Zhang, Yong ^a   Mu, Deguang ^a   Zhao, Pengtao ^b   Zhang, Bo ^b   Cao, Fale ^a   Wang, Yanxia ^b   Jin, Faguang ^a   Li, Zhichao ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

Author keywords

AQP1; AQP5; Lung injury; Tanshinone IIA

Indexed keywords

AQUAPORIN 1; AQUAPORIN 5; MESSENGER RNA; SEA WATER; TANSHINONE IIA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD GAS ANALYSIS; CELL CULTURE; CONTROLLED STUDY; HISTOPATHOLOGY; LUNG; LUNG ALVEOLUS CELL TYPE 2; LUNG EDEMA; LUNG INJURY; LUNG PARENCHYMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; AQUAPORIN 1; AQUAPORIN 5; BLOTTING, WESTERN; CELL LINE; DISEASE MODELS, ANIMAL; DITERPENES, ABIETANE; DROWNING; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY DISTRESS SYNDROME, ADULT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEAWATER;

EID: 79952438012     PISSN: 15699048     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resp.2011.01.005     Document Type: Article

References (41)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 2001, 29:1303-1310.
2. Bai C., Fukuda N., Song Y., Ma T., Matthay M.A., Verkman A.S. Lung fluid transport in aquaporin-1 and aquaporin-4 knockout mice. J. Clin. Invest. 1999, 103:555-561.
3. Bernard G.R. Acute respiratory distress syndrome: a historical perspective. Am. J. Respir. Crit. Care Med. 2005, 172:798-806.
4. Borgnia M., Nielsen S., Engel A., Agre P. Cellular and molecular biology of the aquaporin water channels. Annu. Rev. Biochem. 1999, 68:425-458.
5. Brun-Buisson C., Minelli C., Bertolini G., Brazzi L., Pimentel J., Lewandowski K., Bion J., Romand J.A., Villar J., Thorsteinsson A., Damas P., Armaganidis A., Lemaire F. Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med. 2004, 30:51-61.
6. +-ATPase. J. Biol. Chem. 2003, 278:31352-31360.
7. Costa E.L, Schettino I.A., Schettino G.P. The lung in sepsis: guilty or innocent?. Endocr. Metab. Immune Disord. Drug Targets 2006, 6:213-216.
8. Dobbs L.G., Gonzalez R., Williams M.C. An improved method for isolating type II cells in high yield and purity. Am. Rev. Respir. Dis. 1986, 134:141-145.
9. Effros R.M., Darin C., Jacobs E.R., Rogers R.A., Krenz G., Schneeberger E.E. Water transport and the distribution of aquaporin-1 in pulmonary air spaces. J. Appl. Physiol. 1997, 83:1002-1016.
10. Frutos-Vivar F., Ferguson N.D., Esteban A. Epidemiology of acute lung injury and acute respiratory distress syndrome. Semin. Respir. Crit. Care Med. 2006, 27:327-336.
11. Funaki H., Yamamoto T., Koyama Y., Kondo D., Yaoita E., Kawasaki K., Kobayashi H., Sawaguchi S., Abe H., Kihara I. Localization and expression of AQP5 in cornea, serous salivary glands, and pulmonary epithelial cells. Am. J. Physiol. 1998, 275:C1151-C1157.
12. Gabazza E.C., Kasper M., Ohta K., Keane M., D'Alessandro-Gabazza C., Fujimoto H., Nishii Y., Nakahara H., Takagi T., Menon A.G., Adachi Y., Suzuki K., Taguchi O. Decreased expression of aquaporin-5 in bleomycin-induced lung fibrosis in the mouse. Pathol. Int. 2004, 54:774-780.
13. Han J.Y., Fan J.Y., Horie Y., Miura S., Cui D.H., Ishii H., Hibi T., Tsuneki H., Kimura I. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacol. Ther. 2008, 117:280-295.
14. Hoffert J.D., Leitch V., Agre P., King L.S. Hypertonic induction of aquaporin-5 expression through an ERK-dependent pathway. J. Biol. Chem. 2000, 275:9070-9077.
15. Jiao G., Li E., Yu R. Decreased expression of AQP1 and AQP5 in acute injured lungs in rats. Chin. Med. J. (Engl.) 2002, 115:963-967.
16. King L.S., Kozono D., Agre P. From structure to disease: the evolving tale of aquaporin biology. Nat. Rev. Mol. Cell. Biol. 2004, 5:687-698.
17. King L.S., Nielsen S., Agre P. Aquaporin-1 water channel protein in lung: ontogeny, steroid-induced expression, and distribution in rat. J. Clin. Invest. 1996, 97:2183-2191.
18. King L.S., Nielsen S., Agre P., Brown R.H. Decreased pulmonary vascular permeability in aquaporin-1-null humans. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:1059-1063.
19. Krane C.M., Goldstein D.L. Comparative functional analysis of aquaporins/glyceroporins in mammals and anurans. Mamm. Genome 2007, 18:452-462.
20. Kreda S.M., Gynn M.C., Fenstermacher D.A., Boucher R.C., Gabriel S.E. Expression and localization of epithelial aquaporins in the adult human lung. Am. J. Respir. Cell. Mol. Biol. 2001, 24:224-234.
21. Nielsen S., King L.S., Christensen B.M., Agre P. Aquaporins in complex tissues. II. Subcellular distribution in respiratory and glandular tissues of rat. Am. J. Physiol. 1997, 273:C1549-1561.
22. Ohinata A., Nagai K., Nomura J., Hashimoto K., Hisatsune A., Miyata T., Isohama Y. Lipopolysaccharide changes the subcellular distribution of aquaporin 5 and increases plasma membrane water permeability in mouse lung epithelial cells. Biochem. Biophys. Res. Commun. 2005, 326:521-526.
23. Rubenfeld G.D., Herridge M.S. Epidemiology and outcomes of acute lung injury. Chest 2007, 131:554-562.
24. Sato K., Kobayashi K., Aida S., Tamai S. Bronchiolar expression of aquaporin-3 (AQP3) in rat lung and its dynamics in pulmonary oedema. Pflugers Arch. 2004, 449:106-114.
25. Schnitzer J.E., Oh P. Aquaporin-1 in plasma membrane and caveolae provides mercury-sensitive water channels across lung endothelium. Am. J. Physiol. 1996, 270:H416-422.
26. Song Y., Jayaraman S., Yang B., Matthay M.A., Verkman A.S. Role of aquaporin water channels in airway fluid transport, humidification, and surface liquid hydration. J. Gen. Physiol. 2001, 117:573-582.
27. Song Y., Ma T., Matthay M.A., Verkman A.S. Role of aquaporin-4 in airspace-to-capillary water permeability in intact mouse lung measured by a novel gravimetric method. J. Gen. Physiol. 2000, 115:17-27.
28. Song Y., Yang B., Matthay M.A., Ma T., Verkman A.S. Role of aquaporin water channels in pleural fluid dynamics. Am. J. Physiol. Cell Physiol. 2000, 279:C1744-C1750.
29. Su X., Song Y., Jiang J., Bai C. The role of aquaporin-1 (AQP1) expression in a murine model of lipopolysaccharide-induced acute lung injury. Respir. Physiol. Neurobiol. 2004, 142:1-11.
30. Tang C., Xue H., Bai C., Fu R., Wu A. The effects of Tanshinone IIA on blood-brain barrier and brain edema after transient middle cerebral artery occlusion in rats. Phytomedicine 2010, 17:1145-1149.
31. Towne J.E., Harrod K.S., Krane C.M., Menon A.G. Decreased expression of aquaporin (AQP)1 and AQP5 in mouse lung after acute viral infection. Am. J. Respir. Cell. Mol. Biol. 2000, 22:34-44.
32. Towne J.E., Krane C.M., Bachurski C.J., Menon A.G. Tumor necrosis factor-alpha inhibits aquaporin 5 expression in mouse lung epithelial cells. J. Biol. Chem. 2001, 276:18657-18664.
33. Verkman A.S. Aquaporin water channels and endothelial cell function. J. Anat. 2002, 200:617-627.
34. Wang K., Feng Y.L., Wen F.Q., Chen X.R., Ou X.M., Xu D., Yang J., Deng Z.P. Decreased expression of human aquaporin-5 correlated with mucus overproduction in airways of chronic obstructive pulmonary disease. Acta Pharmacol. Sin. 2007, 28:1166-1174.
35. Ware L.B., Matthay M.A. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 2001, 163:1376-1383.
36. Wiener-Kronish J.P., Albertine K.H., Matthay M.A. Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. J. Clin. Invest. 1991, 88:864-875.
37. Woo J., Chae Y.K., Jang S.J., Kim M.S., Baek J.H., Park J.C., Trink B., Ratovitski E., Lee T., Park B., Park M., Kang J.H., Soria J.C., Lee J., Califano J., Sidransky D., Moon C. Membrane trafficking of AQP5 and cAMP dependent phosphorylation in bronchial epithelium. Biochem. Biophys. Res. Commun. 2008, 366:321-327.
38. Xu M., Dong M.Q., Cao F.L., Liu M.L., Wang Y.X., Dong H.Y., Huang Y.F., Liu Y., Wang X.B., Zhang B., Zhao P.T., Luo Y., Niu W., Cui Y., Li Z.C. Tanshinone IIA reduces lethality and acute lung injury in LPS-treated mice by inhibition of PLA2 activity. Eur. J. Pharmacol. 2009, 607:194-200.
39. Yang F., Kawedia J.D., Menon A.G. Cyclic AMP regulates aquaporin 5 expression at both transcriptional and post-transcriptional levels through a protein kinase A pathway. J. Biol. Chem. 2003, 278:32173-32180.
40. Zhang W.J., Feng J., Zhou R., Ye L.Y., Liu H.L., Peng L., Lou J.N., Li C.H. Tanshinone IIA protects the human blood-brain barrier model from leukocyte-associated hypoxia-reoxygenation injury. Eur. J. Pharmacol. 2010, 648:146-152.
41. Zhou L., Zuo Z., Chow M.S. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J. Clin. Pharmacol. 2005, 45:1345-1359.